| Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use KF Kerr, MD Brown, K Zhu, H Janes Journal of Clinical Oncology 34 (21), 2534, 2016 | 454 | 2016 |
| Evaluating the four kallikrein panel of the 4Kscore for prediction of high-grade prostate cancer in men in the Canary Prostate Active Surveillance Study DW Lin, LF Newcomb, MD Brown, DD Sjoberg, Y Dong, JD Brooks, ... European urology 72 (3), 448-454, 2017 | 90 | 2017 |
| Validation of a Novel Biomarker Panel for the Detection of Ovarian CancerSerum Multimarker Test for the Detection of Ovarian Cancer F Leung, MQ Bernardini, MD Brown, Y Zheng, R Molina, RC Bast, G Davis, ... Cancer Epidemiology, Biomarkers & Prevention 25 (9), 1333-1340, 2016 | 78 | 2016 |
| Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach I Begcevic, D Brinc, M Brown, E Martinez-Morillo, O Goldhardt, T Grimmer, ... Journal of Proteomics 182, 12-20, 2018 | 75 | 2018 |
| 17-Gene genomic prostate score test results in the Canary Prostate Active Surveillance Study (PASS) cohort DW Lin, Y Zheng, JK McKenney, MD Brown, R Lu, M Crager, H Boyer, ... Journal of Clinical Oncology 38 (14), 1549, 2020 | 73 | 2020 |
| An approach to evaluating and comparing biomarkers for patient treatment selection H Janes, MD Brown, Y Huang, MS Pepe The international journal of biostatistics 10 (1), 99-121, 2014 | 67 | 2014 |
| Comparing gene set analysis methods on single-nucleotide polymorphism data from Genetic Analysis Workshop 16 NL Tintle, B Borchers, M Brown, A Bekmetjev BMC proceedings 3 (7), 1-5, 2009 | 57 | 2009 |
| Inferring coancestry in population samples in the presence of linkage disequilibrium MD Brown, CG Glazner, C Zheng, EA Thompson Genetics 190 (4), 1447-1460, 2012 | 47 | 2012 |
| Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression I Begcevic, M Tsolaki, D Brinc, M Brown, E Martinez-Morillo, I Lazarou, ... F1000Research 7, 2018 | 45 | 2018 |
| Performance of PCA3 and TMPRSS2: ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS) LF Newcomb, Y Zheng, AV Faino, D Bianchi-Frias, MR Cooperberg, ... Prostate cancer and prostatic diseases 22 (3), 438-445, 2019 | 34 | 2019 |
| Searching for prognostic biomarkers for small renal masses in the urinary proteome A Di Meo, I Batruch, MD Brown, C Yang, A Finelli, MA Jewett, ... International journal of cancer 146 (8), 2315-2325, 2020 | 24 | 2020 |
| Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease B Lim, M Tsolaki, A Soosaipillai, M Brown, M Zilakaki, F Tagaraki, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (12), 1875-1881, 2019 | 24 | 2019 |
| Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS) EP Diamandis, FZ Stanczyk, S Wheeler, A Mathew, M Stengelin, ... Clinical Chemistry and Laboratory Medicine (CCLM) 55 (11), 1789-1797, 2017 | 24 | 2017 |
| Prognostic urinary miRNAs for the assessment of small renal masses A Di Meo, MD Brown, A Finelli, MAS Jewett, EP Diamandis, GM Yousef Clinical Biochemistry 75, 15-22, 2020 | 21 | 2020 |
| Evaluating incremental values from new predictors with net reclassification improvement in survival analysis Y Zheng, L Parast, T Cai, M Brown Risk Assessment and Evaluation of Predictions, 425-445, 2013 | 20 | 2013 |
| Comparing the accuracy of digital subtraction angiography, CT angiography and MR angiography at estimating the volume of cerebral aneurysms M Hanley, WJ Zenzen, MD Brown, JR Gaughen, AJ Evans Interventional Neuroradiology 14 (2), 173-177, 2008 | 20 | 2008 |
| Designing a study to evaluate the benefit of a biomarker for selecting patient treatment H Janes, MD Brown, MS Pepe Statistics in medicine 34 (27), 3503-3515, 2015 | 17 | 2015 |
| Identification of prognostic biomarkers in the urinary peptidome of the small renal mass A Di Meo, I Batruch, MD Brown, C Yang, A Finelli, MAS Jewett, ... The American journal of pathology 189 (12), 2366-2376, 2019 | 15 | 2019 |
| Assessing the clinical impact of risk models for opting out of treatment KF Kerr, MD Brown, TL Marsh, H Janes Medical Decision Making 39 (2), 86-90, 2019 | 14 | 2019 |
| Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women E Eklund, EP Diamandis, C Muytjens, S Wheeler, A Mathew, M Stengelin, ... F1000Research 6, 2017 | 10 | 2017 |
